08-Apr-2014 - Bristol-Myers Squibb has extended its partnership with DKSH to provide commercialization and distribution services across Southeast Asia.
01-Apr-2014 - Quality and IP issues are driving firms back to the US and Europe for their contract manufacturing according to experts, but Kemwell says there are still opportunities for Indian CMOs.
25-Mar-2014 - AmerisourceBergen (ABC) plans to buy a minority stake in a Brazilian drug wholesaler and outlined plans for a $100m distribution services joint-venture in the rapidly expanding market.
17-Mar-2014 - Aesica has predicted that CMO sector consolidation will continue and hinted that it is considering strategic acquisitions as a part of a bid to generate $1bn revenue.
13-Mar-2014 - Preclinical CRO Charles River Labs has announced plans to buy discovery services firms Argenta and BioFocus from Galapagos NV.
11-Mar-2014 - Nearly a quarter of drugs made in Jammu & Kashmir and 10% of those produced in Himachal Pradesh are substandard according to new testing data published by CDSCO.
10-Mar-2014 - WuXi PharmaTech has revealed that demand for its manufacturing services increased significantly last year and forecast that its "open access" approach will help it sustain growth into 2014.
10-Mar-2014 - In a sign of further consolidation, CRO INC Research has acquired CRO MEK Consulting and will absorb its more than 40 employees based in the Middle East and north Africa.
03-Mar-2014 - Scientists developing vaccines for potentially deadly diseases like influenza, SARS and HIV struggle to find a CRO with the right capabilities according to contractor TNO Triskelion.
25-Feb-2014 - CRO Pharmaceutical Product Development (PPD) and the Charité – Universitätsmedizin hospital in Berlin are collaborating to increase the volume of clinical trials conducted in Germany.
24-Feb-2014 - Icon says it intends to continue its M&A strategy focusing on capabilities, geographies and technologies as it reports a robust 2013.
19-Feb-2014 - DKSH has acquired Macau-based distributor Glory and says demand for Asian market access is being driven from both Western and local pharma firms.
03-Feb-2014 - Parexel narrowly beat investment analysts’ earnings per share and revenue expectations as consolidated service revenue hit $487.1m.
22-Jan-2014 - CEO Tom Pike emphasised Quintiles’ credentials as a Big Pharma collaborator and highlighted personalised medicines as a key driver for the CRO at an investment conference last week.
20-Jan-2014 - AMRI says it intends to expand its fill/finish capability and progress its business into higher value technology following the recent all clear at its once troubled Burlington facility.
20-Jan-2014 - Strategic relationships with both big pharma and mid-tier firms will drive future growth, says Charles River laboratories (CRL).
20-Jan-2014 - WuXi PharmaTech has raised its 2013 financial guidance and now expects to achieve total revenues for 2013 of approximately $578m (€424m).
13-Jan-2014 - AMEC has announced its plan to buy US firm Foster Wheeler AG for $3.2bn (€2.3bn) in a deal that includes the latter’s pharmaceutical plant design services business.
18-Dec-2013 - CMO Recipharm has set out to sell a new own-brand infectious disease medication it developed in partnership with fellow Sweden-based firm Astimex Pharma.
18-Dec-2013 - Contract sales and marketing people who want to work for GSK should think about adopting the new target-free remuneration policy the UK pharmaceutical firm outlined earlier this week.
11-Dec-2013 - The increasingly crowded Chinese preclinical model market gained a new entrant last month with US preclinical CRO Crown Bioscience partnering with Shanghai academics to set up a research centre.
10-Dec-2013 - Venn Life Sciences has purchased Belfast, UK CRO Medevol in its second acquisition in as many months.
05-Dec-2013 - A lawsuit alleging that the US FDA unlawfully detained a batch of acetaminophen API destined for CMO Gemini Pharmaceuticals could have significant impact on the drug industry's definition of an...
03-Dec-2013 - Soon to merge CMO Patheon has increased solid dosage form production capacity at its site in the UK and posted an improved set of preliminary results for the financial year.
21-Nov-2013 - Economic uncertainty and a bleak fiscal outlook will lead to over-regulation and increased fines in the clinical trial industry, according to an economic expert at PCT.